Standout Papers
- Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes (2012)
- Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial (2005)
- Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment (1998)
- Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen (2009)
- Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update (2006)
Immediate Impact
9 by Nobel laureates 10 from Science/Nature 138 standout
Citing Papers
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
2020 Standout
Breast Cancer Treatment
2019 Standout
Works of Manfred Kaufmann being referenced
Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study
2009
Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
2009 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Manfred Kaufmann | 8126 | 6688 | 3435 | 149 | 14.1k | |
| D. Craig Allred | 9370 | 7250 | 5551 | 110 | 15.9k | |
| Wedad Hanna | 10313 | 7354 | 4525 | 156 | 16.5k | |
| Reiki Nishimura | 6761 | 6172 | 5389 | 131 | 13.2k | |
| Lyndsay N. Harris | 9109 | 5405 | 5021 | 188 | 14.6k | |
| Margaret A. Tucker | 7182 | 2820 | 4580 | 229 | 15.6k | |
| Peggy L. Porter | 7362 | 3820 | 4045 | 140 | 12.9k | |
| C.W. Elston | 5586 | 6511 | 2767 | 95 | 11.1k | |
| David G. Hicks | 6082 | 3824 | 4347 | 183 | 12.0k | |
| Jan G.M. Klijn | 6032 | 5873 | 6576 | 148 | 16.5k | |
| Aňa Lluch | 10044 | 5995 | 4032 | 303 | 14.3k |
All Works
Loading papers...